Matches in SemOpenAlex for { <https://semopenalex.org/work/W2912485785> ?p ?o ?g. }
- W2912485785 endingPage "32" @default.
- W2912485785 startingPage "25" @default.
- W2912485785 abstract "BackgroundDifferential treatment allocation may impact on clinical phenotype in MS and in turn upon quality of life (QoL).Objectives(a) Investigate the association between disease-modifying drugs (DMDs) use and relapse frequency, disability, clinically significant fatigue, and physical and mental health-related QoL among participants with MS residing in Australia and New Zealand (NZ); (b) assess whether these associations differed between Australia and NZ.MethodsDisability and fatigue were measured by PDDS and FSS, respectively. QoL was assessed by MSQOL-54. Associations were assessed by binomial and multinomial logistic regression, as appropriate. Multivariable models were adjusted for demographic and clinical covariates, as appropriate.Results837 participants (627 from Australia; 210 from NZ) were identified from an online cohort of people with MS. First- and second-generation DMD use was associated with higher adjusted-odds of fatigue and disability, though not with 12-month relapse number. DMD use was not independently associated with physical or mental QoL. The association of first-generation DMD use with moderate disability differed between nations, such that treatment was associated with lower odds in Australia but not in NZ; a similar but a small difference was found for severe disability. No differences were seen in the DMD association with relapse number, nor with fatigue or QoL, between Australia and NZ.ConclusionThe differential treatment allocation associations in NZ are evident in the DMD-disability association, but there is no evidence that this treatment regimen has negative associations with fatigue, mood, or QoL." @default.
- W2912485785 created "2019-02-21" @default.
- W2912485785 creator A5013908796 @default.
- W2912485785 creator A5013959040 @default.
- W2912485785 creator A5038756631 @default.
- W2912485785 creator A5042142014 @default.
- W2912485785 creator A5048516824 @default.
- W2912485785 creator A5056649801 @default.
- W2912485785 creator A5071519337 @default.
- W2912485785 creator A5071835373 @default.
- W2912485785 creator A5072695355 @default.
- W2912485785 creator A5089421816 @default.
- W2912485785 date "2019-05-01" @default.
- W2912485785 modified "2023-10-16" @default.
- W2912485785 title "Differential multiple sclerosis treatment allocation between Australia and New Zealand associated with clinical outcomes but not mood or quality of life" @default.
- W2912485785 cites W1815777112 @default.
- W2912485785 cites W1971040798 @default.
- W2912485785 cites W1986934752 @default.
- W2912485785 cites W1996308597 @default.
- W2912485785 cites W2011494492 @default.
- W2912485785 cites W2020481916 @default.
- W2912485785 cites W2054777157 @default.
- W2912485785 cites W2065455682 @default.
- W2912485785 cites W2074977960 @default.
- W2912485785 cites W2076989760 @default.
- W2912485785 cites W2107085587 @default.
- W2912485785 cites W2114242035 @default.
- W2912485785 cites W2115755300 @default.
- W2912485785 cites W2120221772 @default.
- W2912485785 cites W2130419605 @default.
- W2912485785 cites W2142254845 @default.
- W2912485785 cites W2171129594 @default.
- W2912485785 cites W2327614140 @default.
- W2912485785 cites W24020054 @default.
- W2912485785 cites W2527555398 @default.
- W2912485785 cites W2548517655 @default.
- W2912485785 cites W2580622791 @default.
- W2912485785 cites W2768978171 @default.
- W2912485785 cites W2783703447 @default.
- W2912485785 doi "https://doi.org/10.1016/j.msard.2019.01.037" @default.
- W2912485785 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30731236" @default.
- W2912485785 hasPublicationYear "2019" @default.
- W2912485785 type Work @default.
- W2912485785 sameAs 2912485785 @default.
- W2912485785 citedByCount "2" @default.
- W2912485785 countsByYear W29124857852021 @default.
- W2912485785 countsByYear W29124857852022 @default.
- W2912485785 crossrefType "journal-article" @default.
- W2912485785 hasAuthorship W2912485785A5013908796 @default.
- W2912485785 hasAuthorship W2912485785A5013959040 @default.
- W2912485785 hasAuthorship W2912485785A5038756631 @default.
- W2912485785 hasAuthorship W2912485785A5042142014 @default.
- W2912485785 hasAuthorship W2912485785A5048516824 @default.
- W2912485785 hasAuthorship W2912485785A5056649801 @default.
- W2912485785 hasAuthorship W2912485785A5071519337 @default.
- W2912485785 hasAuthorship W2912485785A5071835373 @default.
- W2912485785 hasAuthorship W2912485785A5072695355 @default.
- W2912485785 hasAuthorship W2912485785A5089421816 @default.
- W2912485785 hasBestOaLocation W29124857851 @default.
- W2912485785 hasConcept C117568660 @default.
- W2912485785 hasConcept C118552586 @default.
- W2912485785 hasConcept C119857082 @default.
- W2912485785 hasConcept C126322002 @default.
- W2912485785 hasConcept C134362201 @default.
- W2912485785 hasConcept C142853389 @default.
- W2912485785 hasConcept C143095724 @default.
- W2912485785 hasConcept C151956035 @default.
- W2912485785 hasConcept C156957248 @default.
- W2912485785 hasConcept C15744967 @default.
- W2912485785 hasConcept C159110408 @default.
- W2912485785 hasConcept C1862650 @default.
- W2912485785 hasConcept C2779951463 @default.
- W2912485785 hasConcept C2780733359 @default.
- W2912485785 hasConcept C41008148 @default.
- W2912485785 hasConcept C542102704 @default.
- W2912485785 hasConcept C71924100 @default.
- W2912485785 hasConcept C72563966 @default.
- W2912485785 hasConcept C74909509 @default.
- W2912485785 hasConceptScore W2912485785C117568660 @default.
- W2912485785 hasConceptScore W2912485785C118552586 @default.
- W2912485785 hasConceptScore W2912485785C119857082 @default.
- W2912485785 hasConceptScore W2912485785C126322002 @default.
- W2912485785 hasConceptScore W2912485785C134362201 @default.
- W2912485785 hasConceptScore W2912485785C142853389 @default.
- W2912485785 hasConceptScore W2912485785C143095724 @default.
- W2912485785 hasConceptScore W2912485785C151956035 @default.
- W2912485785 hasConceptScore W2912485785C156957248 @default.
- W2912485785 hasConceptScore W2912485785C15744967 @default.
- W2912485785 hasConceptScore W2912485785C159110408 @default.
- W2912485785 hasConceptScore W2912485785C1862650 @default.
- W2912485785 hasConceptScore W2912485785C2779951463 @default.
- W2912485785 hasConceptScore W2912485785C2780733359 @default.
- W2912485785 hasConceptScore W2912485785C41008148 @default.
- W2912485785 hasConceptScore W2912485785C542102704 @default.
- W2912485785 hasConceptScore W2912485785C71924100 @default.
- W2912485785 hasConceptScore W2912485785C72563966 @default.
- W2912485785 hasConceptScore W2912485785C74909509 @default.
- W2912485785 hasFunder F4320306896 @default.